Acetoacetic acid is an organic acid in the ketone body family, produced in hepatic mitochondria from acetyl‑CoA during ketogenesis. It interconverts with beta‑hydroxybutyrate and can decarboxylate to acetone; it is commonly measured in urine and organic acid testing as a marker of ketone metabolism. Biologically, acetoacetate provides an alternative fuel for brain, heart, and muscle during fasting, prolonged exercise, or reduced carbohydrate availability. Levels reflect the balance of fatty acid oxidation, hepatic ketone production, peripheral ketone use, and systemic redox state, offering insight into mitochondrial and metabolic function.

Elevated acetoacetic acid levels may reflect increased ketogenesis and greater reliance on fat-derived fuels — for example during prolonged fasting, very low‑carbohydrate diets, extended exercise, or shifts in mitochondrial fatty acid handling. Elevated measurements can also occur when peripheral ketone clearance is reduced or when the redox balance favors acetoacetate over beta‑hydroxybutyrate. Interpretation requires clinical context and comparison with other Cellular Zoomer markers such as beta‑hydroxybutyrate, Krebs cycle intermediates, and oxidative stress indicators. Low levels typically indicate limited ketone production, consistent with high carbohydrate availability, suppressed fat oxidation, reduced fatty acid mobilization, or preferential conversion to other metabolites. Low acetoacetate alone does not rule out metabolic imbalance; it is most informative when evaluated alongside complementary energy and nutrient markers on the full panel.

Acetoacetic acid is included in the Cellular Zoomer to report ketone production and shifts in fuel utilization. Alongside organic acids, redox markers, and antioxidant genetics, it helps map mitochondrial fuel flexibility and fatty acid oxidation to refine metabolic assessment and personalize care.